Medicinal Cannabis. From Africa to Europe.
Frontier Botanics is building one of Africa’s lowest-cost, highest-quality medicinal cannabis platforms. Already operational and GACP-certified, we are positioned at the forefront of Europe’s fastest-growing pharmaceutical market.
Capital at risk · Available to High Net Worth & Sophisticated Investors only · Risk warning
- 1,500 mAbove sea level
- 2,500+Hours of sun a year
- GACPCertified · EU standard
- End 2026EU-GMP facility target
The investment case, in six points
A quick summary of the thesis, drawn from the pages that follow. Targets and estimates are management’s own and are not guarantees.
Already operational and GACP-certified
A secured site with access control and irrigation, certified to the EU standard for agricultural-stage production.
See the siteBuilt on Africa’s lowest-cost base
At around 1,500 m in Lesotho, labour, land and energy costs are a fraction of European equivalents.
Why LesothoRetained ownership, sold direct
Toll processing keeps product ownership with us. Management estimates this approximately doubles revenue per batch versus outright sales.
The modelA structural supply deficit in Europe
European cultivation capacity remains structurally insufficient, so the continent relies heavily on imports.
The marketA clear route from GACP to EU-GMP
Established GMP partners in the near term, with our own EU-GMP facility targeted by the end of 2026.
The pathwayOperational for a fraction of the capital
We reached operational status for a fraction of the capital consumed by comparable ventures, most of which no longer exist.
The companyA message from our CEO
Frontier Botanics is building one of Africa’s lowest-cost, highest-quality medicinal cannabis platforms. Already operational and GACP-certified, we are positioned at the forefront of Europe’s fastest-growing pharmaceutical market.
Grow at the lowest cost. Sell at the highest value.
Frontier Botanics operates across the full medicinal cannabis value chain: cultivation, processing, and distribution. Our model is built on three principles.
Produce at Africa’s Lowest Cost
Outdoor volume plus indoor Sea of Green for premium, year-round production. GACP certification ensures every gram meets EU pharmaceutical standards.
Cultivation
Process Into Premium Products
Dried flower is the commodity. Rosin and pharmaceutical extracts are the premium products, built around the highest-value formats.
Processing
Retain Ownership, Sell Direct
Through toll processing we retain product ownership and sell directly to European distributors at pharmaceutical wholesale prices.
Our approach
One origin. Two markets.
Europe is the prize. South Africa is the opportunity next door. From Lesotho, we can serve both.
- Cultivate — Maseru, Lesotho1,500 m · GACP-certified
- Process — EU-GMP partnersToll processing · own facility targeted end 2026
- Sell — German & EU distributorsPharmaceutical wholesale prices · ownership retained
- Next door — South Africa60 million+ people · no cross-continental shipping
Why Lesotho Offers a Strategic Advantage
A unique combination of ideal growing conditions, progressive regulation, and cost-efficient production makes Lesotho a prime location for scalable medical cannabis cultivation.
Video loads from YouTube (privacy-enhanced mode) only when you press play.
Climate
High-altitude subtropical conditions deliver exceptional light intensity, low humidity and natural pest resistance.
Cost
Labour, land and energy costs are a fraction of European equivalents.
Regulatory First Mover
The first African country to grant licences for medicinal cannabis cultivation and export.
EU Trade Access
Exportable to EU markets under the same GACP frameworks that govern pharmaceutical raw material supply chains.
Our Facility In The Kingdom Of Lesotho
Located in the heart of Lesotho, our cultivation facility benefits from an ideal combination of high altitude, clean air, and abundant sunlight—creating optimal conditions for producing premium, pharmaceutical-grade medical cannabis. The region’s stable climate allows for consistent, year-round growing, supporting both quality control and scalable output.
Built to meet strict international standards, the facility integrates modern agricultural technology with rigorous compliance protocols. From cultivation through to processing, every stage is carefully managed to ensure product consistency, traceability, and alignment with global medical and export regulations.
The Opportunity
The global medicinal cannabis market is undergoing a structural shift. Regulatory reform across Europe, combined with growing clinical evidence and patient demand, is creating a multi-billion-pound opportunity that is still in its earliest stages.
High-growth market
Positioned within a rapidly expanding global medical cannabis industry with strong long-term demand.
Scalable operations
Established cultivation in Lesotho allows for cost-efficient, large-scale production.
Regulatory alignment
Operating within fully legal, compliant frameworks across both African and UK markets.
First-mover advantage
Early positioning in an evolving sector with increasing medical adoption and limited established competition.
Where we are, and where we’re going
We achieved operational status for a fraction of the capital consumed by comparable ventures. The next steps build the full value chain in-house.
Operational & GACP-certified
Secured site with perimeter fencing, access control and irrigation infrastructure. GACP certification in place.
Route to market
Active discussions with EU GMP-certified processing and distribution partners with proven German market access.
Phase 2 greenhouse
A larger greenhouse to materially increase indoor capacity, designed to be self-funding from operating cash flow.
Own EU-GMP facility
EU-GMP certification targeted with completion of our dedicated processing facility, bringing the value chain in-house.
Targets and plans are not guarantees and are subject to regulatory approval, funding and delivery risk. See the risk warning.
The people behind the platform
A lean, experienced management team spanning finance, medicine and law.
Iain Richardson
CEO & FounderEntrepreneurial background across multiple sectors, with deep knowledge of Lesotho and Southern African business. Direct oversight of all cultivation operations.
James Simpson
Finance DirectorFinancial management and corporate governance. Responsible for capital allocation, investor relations and financial modelling.
How The Investment Process Works
A simple, transparent process designed to guide you from initial interest through to securing your investment with confidence.
Register Interest
Submit your details to receive the investor pack and key information about the opportunity.
Review Documentation
Assess financials, projections, and operational plans to understand the growth strategy.
Speak with the Team
Engage directly with the Frontier Botanics team to ask questions and gain deeper insight.
Secure Your Investment
Complete the required agreements and formally participate in the funding round.
Investing At Your Comfort Level
Flexible opportunities designed to align with your investment goals while supporting scalable growth and long-term value creation.
What the current funding round is for
Expand cultivation capacity
Increase production output at our Maseru site.
Enhance processing facilities
Building towards our own EU-GMP certification.
Secure distribution partnerships
Extending our route to market in Germany and the EU.
Seed Investor
- Early access to a high-growth medical cannabis opportunity
- Lower minimum investment threshold
- Entry-level equity participation
- Regular investor updates and performance reports
- Opportunity to scale investment in future rounds
Growth Investor
- Priority allocation within the current funding round
- Enhanced equity position with competitive entry valuation
- Access to detailed financial reporting and projections
- Direct communication with senior leadership
- Participation in key expansion milestones
Strategic Investor
- Premium allocation with significant equity stake
- Potential influence on strategic direction and growth initiatives
- Access to executive-level insights and decision-making discussions
- Tailored investment structuring opportunities
- Priority access to future funding rounds and exits
Capital at risk — in plain English
Early-stage investments can lose all of their value, can be hard to sell, and may be diluted by later funding rounds. We’d rather you hear that from us first.
Available only to eligible High Net Worth Individuals or Sophisticated Investors.
Our frequently asked questions
Everything you need to know about Frontier Botanics, our operations, and the investment opportunity. Still have questions? Our team is happy to walk you through the detail.
Get In TouchIs medical cannabis legal in the UK?
Yes. Medical cannabis has been legal in the UK since November 2018 following changes introduced after high-profile cases like that of Alfie Dingley. However, access is tightly regulated and prescriptions are typically issued by specialist doctors. Frontier Botanics operates fully within UK and international legal frameworks to ensure compliance at every stage of production and distribution.
Why is cultivation based in Lesotho?
Lesotho was the first African nation to legalise medical cannabis cultivation and export, offering a stable regulatory environment, favourable climate, and cost-efficient production conditions. This allows Frontier Botanics to produce high-quality, pharmaceutical-grade cannabis at scale while maintaining competitive pricing for international markets.
What makes Frontier Botanics different from other medical cannabis companies?
Frontier Botanics focuses on vertically integrated operations—from cultivation in Lesotho to distribution in the UK—ensuring full control over quality, compliance, and supply chain efficiency. The company combines pharmaceutical standards with scalable infrastructure, positioning itself to meet growing demand in regulated global markets.
What is the current investment opportunity?
Frontier Botanics is currently raising capital to expand cultivation capacity, enhance processing facilities, and secure additional distribution partnerships. The funding round is designed to accelerate growth, increase production output, and strengthen the company’s position within the rapidly expanding global medical cannabis market.
What is the market potential for medical cannabis?
The global medical cannabis market is projected to grow significantly over the coming decade, driven by increasing legalisation, patient demand, and clinical research. Countries across Europe—including the UK—are gradually expanding access, creating a strong long-term growth opportunity for early-stage, compliant operators like Frontier Botanics.
Get in Touch
Whether you’re an investor, partner, or simply want to learn more about Frontier Botanics, our team is here to help. We welcome enquiries regarding our operations, investment opportunities, and strategic partnerships.
Prefer to talk it through?
Call the team directly. We’re happy to answer questions about the operation or the funding round.
Give Us A Call
Send Us A Message
Visit Our Location
First Floor, 690 Great West Road, Osterley Village, Isleworth, England, TW7 4PU